Paul W. Hoelscher
2019
Compensation breakdown
| Non-Equity Incentive Plan | $968,840 |
|---|---|
| Salary | $580,748 |
| Stock Awards | $2,773,866 |
| Other | $120,135 |
| Total | $4,443,588 |
Hoelscher received $2.8M in stock awards, accounting for 62% of the total pay in 2019.
Hoelscher also received $968.8K in non-equity incentive plan, $580.7K in salary and $120.1K in other compensation.
Rankings
In 2019, Paul W. Hoelscher's compensation ranked 2,588th out of 13,971 executives tracked by ExecPay. In other words, Hoelscher earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,588 out of 13,971 | 82nd |
Division Manufacturing | 927 out of 5,701 | 84th |
Major group Chemicals And Allied Products | 303 out of 2,200 | 86th |
Industry group Drugs | 244 out of 1,886 | 87th |
Industry Pharmaceutical Preparations | 178 out of 1,398 | 87th |
Pay ratio
| Paul W. Hoelscher's Pay | $4,443,588 |
|---|---|
| Median Employee's Pay | $250,565 |
| Pay Ratio | 18to 1 |
In 2019, the annual total compensation of Paul W. Hoelscher was $4,443,588.
The annual total compensation of the median employee at Horizon Pharma was $250,565.
The ratio of Paul W. Hoelscher's pay to the pay of median employee was therefore 18 to one.
Hoelscher's colleagues
We found eight more compensation records of executives who worked with Paul W. Hoelscher at Horizon Pharma in 2019.
2019
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2019
Barry Moze
Horizon Pharma
Chief Administrative Officer
2019
Robert Carey
Horizon Pharma
Former Executive Vice President, Chief Business Officer
2019
Shao-Lee Lin
Horizon Pharma
Chief Scientific Officer
2019
Vikram Karnani
Horizon Pharma
Executive Vice President, Chief Commercial Officer
2019
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
2019
Brian Beeler
Horizon Pharma
General Counsel
2019
Andy Pasternak
Horizon Pharma
Executive Vice President, Chief Strategy Officer
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019